The national group representing the generic drug and biosimilar industry may press on with its lawsuit against an Illinois anti-price gouging law after a federal judge on Thursday denied the state’s motion to dismiss the case.
The Association for Accessible Medicines has until Jan. 3 to file a motion for a preliminary injunction on the Illinois law, Judge
The decision is a win for AAM, which ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.